The California Division of Workers’ Compensation opened a second 15-day comment period on a proposal to incorporate Medi-Cal’s reimbursement rules into its pharmacy fee schedule.
In addition to technical corrections, the division said it revised rules first proposed in February to eliminate the use of documented paid costs as the pricing benchmark for compound drugs and require that the fee for ingredients in compound drugs be based on the same Medi-Cal formula that applies to other drugs.
The DWC in February proposed rules that would adopt Medi-Cal’s dispensing fee and pri...
Comments